利坦丝林 T16759

Product Introduction
Bioactivity


英文名: Ritanserin

描述: Ritanserin (R 55667) 是一种长效、高效、相对选择性、可口服的5-HT2受体拮抗剂，IC50值为 0.9 nM。

体外活性: Ritanserin对多种受体的活性较低，包括Histamine-H1（IC50，35 nM）、Dopamine-D2（IC50，70 nM）、Adrenergic-α1（IC50，97 nM）和Adrenergic-α2受体（IC50，150 nM）[1]。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 50 mg/mL (104.7 mM)


关键字: Inhibitor | Histamine Receptor | 5-hydroxytryptamine Receptor | inhibit | Serotonin Receptor | R-55667 | R55667 | Ritanserin | 5-HT Receptor | Beta Receptor | Adrenergic Receptor | Dopamine Receptor

相关产品: Dexchlorpheniramine Maleate | Eticlopride hydrochloride | U91356 | Mirtazapine | CP-226269 | Pridopidine | Pramipexole | Nuciferine | Pramipexole dihydrochloride | 5-HT6/7 antagonist 1

相关库: Anti-Neurodegenerative Disease Compound Library | Drug Repurposing Compound Library | Neurotransmitter Receptor Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Neuronal Signaling Compound Library | Inhibitor Library | GPCR Compound Library | Anti-Cancer Clinical Compound Library | Endocrinology-Hormone Compound Library

利坦丝林 T16759信息由TargetMol中国为您提供，如您想了解更多关于利坦丝林 T16759报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途